Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2

Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2

The COVID-19 global pandemic is caused by SARS-CoV-2, and represents an urgent medical and social issue. Unfortunately, there is still not a single proven effective drug available, and therefore, current therapeutic guidelines recommend supportive care including oxygen administration and treatment w...

Full description

Bibliographic Details
Main Authors: Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo, Giacomo Lazzarino, Nicola Tartaglia, Sara Galimberti, Giovanni Li Volti, Giuseppe Alberto Palumbo, Arcangelo Liso
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
SARS-CoV-2
proteasome inhibitors
endoplasmic stress
UPR response
Online Access:https://www.mdpi.com/1422-0067/21/10/3622

Similar Items

Similar Items